IXEKIZUMAB

37285 reported adverse events

Drug classes: Interleukin-17A Antagonist [EPC]

These side effects are most commonly reported by patients taking IXEKIZUMAB:

# Side effect Count
0 INJECTION SITE PAIN 3931
1 PSORIASIS 3296
2 DRUG INEFFECTIVE 3287
3 INJECTION SITE ERYTHEMA 2214
4 INJECTION SITE REACTION 1798
5 INJECTION SITE SWELLING 1659
6 INCORRECT DOSE ADMINISTERED 1199
7 PRODUCT DOSE OMISSION ISSUE 962
8 PAIN 950
9 COVID-19 923
See all common reactions for IXEKIZUMAB

IXEKIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MENINGORADICULITIS 10 0.0926
1 DOUBLE STRANDED DNA ANTIBODY 9 0.0789
2 CHRONIC DISEASE 20 0.0784
3 INJECTION SITE PLAQUE 15 0.0714
4 REMOVAL OF INTERNAL FIXATION 10 0.0565
5 ALOPECIA SCARRING 10 0.0546
6 PSORIASIS AREA SEVERITY INDEX INCREASED 9 0.0545
7 CUTANEOUS LYMPHOMA 11 0.0539
8 CARBON DIOXIDE ABNORMAL 15 0.0479
9 GRANULOMA SKIN 35 0.0426
See all enriched reactions for IXEKIZUMAB